Isomorphic Labs Raises $2.1 Billion to Advance AI Drug Discovery
Isomorphic Labs, an AI-driven drug discovery company, raised $2.1 billion in funding led by Thrive Capital. The investment aims to scale their drug design engine, with plans to initiate clinical trials by late 2026 as part of their mission to cure all diseases.
The Economic Times·


